CA1320114C - Methode et trousse pour epreuve de neutralisation/immuno-inhibition - Google Patents
Methode et trousse pour epreuve de neutralisation/immuno-inhibitionInfo
- Publication number
- CA1320114C CA1320114C CA000566474A CA566474A CA1320114C CA 1320114 C CA1320114 C CA 1320114C CA 000566474 A CA000566474 A CA 000566474A CA 566474 A CA566474 A CA 566474A CA 1320114 C CA1320114 C CA 1320114C
- Authority
- CA
- Canada
- Prior art keywords
- isoenzyme
- sample
- serum
- diagnostically relevant
- immunoinhibition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
- G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US4871287A | 1987-05-12 | 1987-05-12 | |
US07/048,712 | 1987-05-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA1320114C true CA1320114C (fr) | 1993-07-13 |
Family
ID=21956040
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA000566474A Expired - Fee Related CA1320114C (fr) | 1987-05-12 | 1988-05-11 | Methode et trousse pour epreuve de neutralisation/immuno-inhibition |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0382725A4 (fr) |
JP (1) | JPH01503565A (fr) |
AU (1) | AU1800088A (fr) |
CA (1) | CA1320114C (fr) |
WO (1) | WO1988008984A1 (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE120551T1 (de) * | 1990-06-21 | 1995-04-15 | Axis Biochemicals As | Analyse der varianten von analyten. |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2548963C3 (de) * | 1975-11-03 | 1982-03-11 | Merck Patent Gmbh, 6100 Darmstadt | Verfahren und Mittel zur Bestimmung der Aktivität von Creatinkinase-MB |
-
1988
- 1988-05-11 WO PCT/US1988/001553 patent/WO1988008984A1/fr not_active Application Discontinuation
- 1988-05-11 AU AU18000/88A patent/AU1800088A/en not_active Abandoned
- 1988-05-11 CA CA000566474A patent/CA1320114C/fr not_active Expired - Fee Related
- 1988-05-11 EP EP19880904874 patent/EP0382725A4/en not_active Withdrawn
- 1988-05-11 JP JP50458888A patent/JPH01503565A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
AU1800088A (en) | 1988-12-06 |
JPH01503565A (ja) | 1989-11-30 |
EP0382725A1 (fr) | 1990-08-22 |
EP0382725A4 (en) | 1990-12-27 |
WO1988008984A1 (fr) | 1988-11-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4067775A (en) | Process and composition for determining the activity of creatinekinase-MB | |
US4515890A (en) | Immunoassay of terminal deoxynucleotidyl transferase | |
JP3686423B2 (ja) | 慢性疲労症候群の検出方法 | |
US7462495B2 (en) | Methods and compositions for use in diagnosing and characterizing chronic immune disease | |
Mulivor et al. | Origin of the alkaline phosphatases in amniotic fluid | |
US4387160A (en) | Immunochemical assay for creatine kinase-MB isoenzyme | |
US4543325A (en) | Process and reagent for the determination of creatinine | |
CA2513317A1 (fr) | Composition contenant de l'aldolase pour le diagnostic d'une maladie vasculaire au niveau de la retine et methode diagnostique connexe | |
EP0636247B1 (fr) | Procede et composition permettant de reduire les effets de la phosphatase alcaline endogene | |
US4237044A (en) | Antibodies against creatinekinase-M8 and process for the production thereof | |
CA1320114C (fr) | Methode et trousse pour epreuve de neutralisation/immuno-inhibition | |
US4673633A (en) | Method of determining cystic fibrosis ciliostatic factor | |
DK164512B (da) | Fremgangsmaade til simultan bestemmelse af prokallikrein og den partielle thromboplastintid | |
US4330620A (en) | Method and reagent for the determination of creatine kinase MB | |
JP4043053B2 (ja) | 生物学上の流体中のプロカルボキシペプチダーゼaおよびカルボキシペプチダーゼaレベルの検出方法 | |
Mbachiantim et al. | Procedural Determination of Porcine Intestinal Alkaline Phosphatase (ALP) Activity Kinetics in Classical Nutrition Research | |
CA1062609A (fr) | Procede et compose pour mesurer l'activite de la creatinekinase-mb | |
Wong et al. | Evaluation of a kinetic assay for angiotensin converting enzyme | |
Lukomskaya et al. | Use of β-maltosides (p-nitrophenyl-β-d-maltoside, 2-chloro-4-nitrophenyl-β-d-maltoside and 4-methylumbelliferyl-β-d-maltoside) as substrates for the assay of neutral α-glucosidase from human kidney and urine | |
US20060269963A1 (en) | Composition for the diagnosis of retinal vascular disease comprising aldolase and method for diagnosis using it | |
JPS6171359A (ja) | ビオチンの測定法およびこれに用いる測定用試薬 | |
Agostoni et al. | Abels, J., see Van Kapel, J.(131) 211 Abraham, RT. see Keith, RA (131) 257 A, Inm hd..... I n,.., 7 i-ua,“A_ Pll”“CJ”, L. Altered expression of collagen phenotype in osteoarthrosis (133) 25 | |
Landon et al. | The Radioimmunoassay of Enzymes | |
Wolk et al. | Quantitation of serum IgM by graded hemagglutination inhibition. | |
JPH11103892A (ja) | アイソザイム活性測定法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MKLA | Lapsed |